Mauro Cerretani
IRBM Science Park · 16 works · 710 citations · h-index 13
Top works
- Binding of Hepatitis C Virus E2 Glycoprotein to CD81 Does Not Correlate with Species Permissiveness to Infection
- Reduction of Hepatitis C Virus NS5A Hyperphosphorylation by Selective Inhibition of Cellular Kinases Activates Viral RNA Replication in Cell Culture
- Engineering human interleukin‐6 to obtain variants with strongly enhanced bioactivity.
- Adipogenesis of skeletal muscle fibro/adipogenic progenitors is affected by the WNT5a/GSK3/β-catenin axis
- Nuclear factor (erythroid-derived 2)-like 2 (NRF2) drug discovery: Biochemical toolbox to develop NRF2 activators by reversible binding of Kelch-like ECH-associated protein 1 (KEAP1)
- Synthesis and biological evaluation of substituted 2-phenyl-2H-indazole-7-carboxamides as potent poly(ADP-ribose) polymerase (PARP) inhibitors
- NRF2 activation by reversible KEAP1 binding induces the antioxidant response in primary neurons and astrocytes of a Huntington's disease mouse model
- Identification of aminoethyl pyrrolo dihydroisoquinolinones as novel poly(ADP-ribose) polymerase-1 inhibitors
- Discovery of a Novel Series of Imidazopyrazine Derivatives as Potent SHP2 Allosteric Inhibitors
- A High-Throughput Radiometric Assay for Hepatitis C Virus NS3 Protease
- Janus effect of glucocorticoids on differentiation of muscle fibro/adipogenic progenitors
- Optimization of linear and cyclic peptide inhibitors of KEAP1-NRF2 protein-protein interaction
- Identification of HSPB8 modulators counteracting misfolded protein accumulation in neurodegenerative diseases
- Adipogenesis of Skeletal Muscle Fibro/Adipogenic Progenitors is Controlled by the WNT5a/GSK3/β-Catenin Axis
- A scintillation proximity active site binding assay for the hepatitis C virus serine protease
- A21 Development of an Nrf2-KEAP1 protein-protein disruptor for proof of concept